Skip to main content
Clinical Trials/NCT07044882
NCT07044882Not yet recruitingNot Applicable

Evaluation of the Hydrodynamic Piezoelectric Technique in Internal Sinus Lift With Simultaneous Implant Placement (A Randomized Controlled Clinical Trial)

Hams Hamed Abdelrahman1 site in 1 country22 target enrollmentStarted: October 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
22
Locations
1
Primary Endpoint
Change in wound healing

Study Overview

Brief Summary

Background: The use of hydrodynamic piezoelectric techniques for trans crestal / internal sinus lift with simultaneous implant placement has gained popularity as a safe and minimally invasive technique for managing the posterior edentulous maxilla, particularly in cases with sinus pneumatization. This method offers a controlled elevation of the Schneiderian membrane while reducing the risk of perforation compared to conventional techniques. Additionally, it minimizes postoperative discomfort and oedema, leading to better acceptance and satisfaction by the patients. In contrast to traditional osteotome tapping procedures, the hydrodynamic piezoelectric technique enhances surgical outcomes while preserving vital anatomical structures, making it a superior alternative in implant dentistry. This study aims to evaluate the use of the hydrodynamic piezoelectric technique in internal sinus lifting with simultaneous implant placement in comparison to the conventional osteotome technique.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
30 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients with edentulous free end or bounded posterior maxilla that require implant supported restoration.
  • •Patients indicated to internal sinus lifting, where insufficient residual alveolar bone height from the alveolar crest to the floor of the maxillary sinus is found.
  • •Patients with residual alveolar bone height that ranges from 5-7 mm according to the tomographic radiographic examination.
  • •A good standard of oral hygiene.

Exclusion Criteria

  • •Patients with residual alveolar bone height less than 5 mm according to the tomographic radiographic examination.
  • •Patients with residual alveolar bone height more than 8 mm according to the tomographic radiographic examination, which is not indicated to sinus lifting.
  • •Patient with active sinus infection or sinus pathology.
  • •History of Oral or intravenous bisphosphonate therapy or any treatments with other medications that may interfere with bone metabolism within the past 12 months.
  • •Heavy smokers.
  • •Medically compromised patients that are burdened with systemic conditions that contradicts implant placement and interfere with wound healing.
  • •Exclusion Criteria:

Arms & Interventions

conventional osteotome technique

Active Comparator

Intervention: conventional osteotome technique (Procedure)

osteotome with hydrodynamic piezoelectric

Experimental

Intervention: Hydrodynamic Piezoelectric technique (Procedure)

Outcomes

Primary Outcomes

Change in wound healing

Time Frame: at 7, 14, and 21 days

The wound healing will be assessed based on the Modified Healing Index. The Wound Healing Index (WHI) evaluates preimplant soft tissue wound healing with scores from 1 to 3. On this scale, a score of 1 indicates ordinary healing with the absence of gingival edema, erythema, suppuration, patient discomfort, and flap dehiscence. A score of 2 indicates ordinary healing with slight gingival edema, erythema, patient discomfort, and flap dehiscence, but no suppuration and a score of 3 corresponds to poor wound healing with significant gingival edema, erythema, patient discomfort, suppuration, and flap dehiscence, or any suppuration

change in implant stability

Time Frame: baseline and 6 months

Implant Stability Quotient (ISQ) will be measured during the operative stage, while the secondary stability quotient will be measured 6-months post-operative during the prosthetic phase preparation using Ostell device.

change in implant stability

Time Frame: baseline and 6 months

Implant Stability Quotient (ISQ) will be measured during the operative stage, while the secondary stability quotient will be measured 6-months post-operative during the prosthetic phase preparation using Ostell device.

Change in wound healing

Time Frame: at 7, 14, and 21 days

The wound healing will be assessed based on the Modified Healing Index. The Wound Healing Index (WHI) evaluates preimplant soft tissue wound healing with scores from 1 to 3. On this scale, a score of 1 indicates ordinary healing with the absence of gingival edema, erythema, suppuration, patient discomfort, and flap dehiscence. A score of 2 indicates ordinary healing with slight gingival edema, erythema, patient discomfort, and flap dehiscence, but no suppuration and a score of 3 corresponds to poor wound healing with significant gingival edema, erythema, patient discomfort, suppuration, and flap dehiscence, or any suppuration

Change in pain scores

Time Frame: at 7, 14, and 21 days

Pain will be evaluated, using visual analogue scale (VAS) as follows: (0-1= None, 2-4= Mild, 5-7= Moderate, 8-10= Severe).

Secondary Outcomes

  • Change in Alveolar Process height gain(baseline and 6 months)
  • Change in Alveolar Process height gain(baseline and 6 months)

Investigators

Sponsor
Hams Hamed Abdelrahman
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Hams Hamed Abdelrahman

Lecturer of Dental Public Health and biostatistical consultanat

Alexandria University

Study Sites (1)

Loading locations...

Similar Trials

Hydrodynamic Piezoelectric Technique in... | Clinical Trial